We are live on ! Find out more
AAP

Ardsley Advisory Partners Portfolio holdings

AUM $960M
1-Year Est. Return 207.76%
This Fund
S&P 500
This Quarter Est. Return
-3.64%
1 Year Est. Return
+207.76%
3 Year Est. Return
+554.53%
5 Year Est. Return
+728.66%
10 Year Est. Return
+4,084.52%
AUM
$656M
AUM Growth
-$195M
Cap. Flow
-$139M
Cap. Flow %
-21.13%
Top 10 Hldgs %
49.69%
Holding
183
New
53
Increased
32
Reduced
34
Closed
57

Top Buys

Rank Stock Value
1
FIVN icon
FIVE9
FIVN
+$13.7M
2
STKL
SunOpta
STKL
+$11.9M
3
ALGN icon
Align Technology
ALGN
+$10.2M
4
ADI icon
Analog Devices
ADI
+$9.9M
5
ALT icon
Altimmune
ALT
+$8.83M

Sector Composition

Rank Sector Weight
1 Technology 28.29%
2 Healthcare 16.51%
3 Industrials 6.01%
4 Consumer Staples 4.88%
5 Materials 4.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CTLP
1
DELISTED
Cantaloupe
CTLP
$53.6M 8.17%
4,973,000
+15,000
+0.3% +$155K
GE icon
2
CALL
GE Aerospace
GE
$377B
$51.5M 7.85%
802,547
+702,229
+700% +$45.2M
TBT icon
3
CALL
ProShares Trust UltraShort Lehman 20+ Year Treasury
TBT
$289M
$44M 6.71%
2,400,000
-2,100,000
-47% -$36.8M
DT icon
4
Dynatrace
DT
$12.7B
$31.6M 4.81%
445,000
-75,850
-15% -$4.97M
HZNP
5
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$30.2M 4.61%
276,000
-9,000
-3% -$934K
AZN icon
6
CALL
AstraZeneca
AZN
$267B
$30M 4.58%
250,000
STKL
7
DELISTED
SunOpta
STKL
$28.7M 4.37%
3,211,000
+1,178,500
+58% +$11.9M
FTAI icon
8
CALL
FTAI Aviation
FTAI
$21.8B
$21.4M 3.27%
989,495
+117,100
+13% +$2.81M
AZN icon
9
AstraZeneca
AZN
$267B
$18.1M 2.75%
150,350
+75,350
+100% +$8.77M
FTAI icon
10
FTAI Aviation
FTAI
$21.8B
$16.8M 2.56%
773,446
+40,400
+6% +$968K
GSM icon
11
FerroAtlántica
GSM
$628M
$15.5M 2.36%
1,776,000
+539,000
+44% +$3.67M
SGRY icon
12
Surgery Partners
SGRY
$2.04B
$12.7M 1.94%
300,000
-21,500
-7% -$1.1M
RUN icon
13
Sunrun
RUN
$2.3B
$12.5M 1.91%
285,000
-130,500
-31% -$6.23M
MBII
14
DELISTED
Marrone Bio Innovations, Inc.
MBII
$12M 1.83%
16,692,753
FIVN icon
15
FIVE9
FIVN
$2.08B
$12M 1.83%
+75,000
New +$13.7M
ALT icon
16
Altimmune
ALT
$581M
$11.7M 1.79%
1,027,500
+726,000
+241% +$8.83M
ADI icon
17
Analog Devices
ADI
$178B
$11.7M 1.78%
69,750
+59,000
+549% +$9.9M
HOLX
18
DELISTED
Hologic
HOLX
$10.4M 1.59%
141,450
+16,450
+13% +$1.23M
ALGN icon
19
Align Technology
ALGN
$12.6B
$9.98M 1.52%
+15,000
New +$10.2M
ENVX icon
20
Enovix
ENVX
$866M
$8.84M 1.35%
534,887
+277,744
+108% +$4.18M
EVA
21
DELISTED
Enviva Inc.
EVA
$8.65M 1.32%
160,000
-55,000
-26% -$2.96M
VST icon
22
Vistra
VST
$50.1B
$8.6M 1.31%
503,000
+350,750
+230% +$6.48M
UPLD icon
23
Upland Software
UPLD
$14.4M
$8.56M 1.31%
25,600
-9,400
-27% -$3.52M
HLIT icon
24
Harmonic Inc
HLIT
$1.2B
$8.49M 1.29%
970,000
+140,000
+17% +$1.25M
AIOT
25
PowerFleet Inc
AIOT
$525M
$7.94M 1.21%
1,185,188
+90,000
+8% +$624K

Similar funds

Ardsley Advisory Partners's Q3 2021 Portfolio in Review

As of Q3 2021, Ardsley Advisory Partners held 183 positions worth $656M, down 23% from $851M the previous quarter. Its ten largest holdings account for 50% of the portfolio.

Ardsley Advisory Partners withdrew a net $139M in Q3 2021, closing 57 positions and reducing 34 holdings. Its most notable exit was T-Mobile US, an estimated $15.6M position sold in full.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 28% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Ardsley Advisory Partners opened a new position in FIVE9 worth $12M.

  • Ardsley Advisory Partners's largest Q3 2021 buy was FIVE9: 75,000 shares worth $12M.
  • Ardsley Advisory Partners added most to SunOpta in Q3 2021, an estimated $11.9M increase.
  • Ardsley Advisory Partners's biggest Q3 2021 reduction was ZENDESK INC, cutting an estimated $20.2M.
  • Ardsley Advisory Partners fully exited T-Mobile US in Q3 2021, selling an estimated $15.6M.
  • Ardsley Advisory Partners's ten largest holdings make up 50% of its $656M portfolio in Q3 2021.
  • Ardsley Advisory Partners opened 53 new positions and closed 57 in Q3 2021.
  • Ardsley Advisory Partners's portfolio value fell 23% quarter-over-quarter to $656M.

Based on Ardsley Advisory Partners's 13F filing for Q3 2021, filed 15 Nov 2021.